This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Qilu Regor Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xudong Wei: Innovator in Pharmaceutical Applications
Introduction: Xudong Wei is an inventor based in Coventry, RI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of cyclic depsipeptides and the development of various salt forms of GLP-1R agonists. Although he currently holds no granted patents, his work is noteworthy for its potential applications in treating various health conditions.
Latest Patent Applications: Xudong Wei's latest patent applications include the following:
1. **Method for the Synthesis of Cyclic Depsipeptides**: This invention relates to a method for synthesizing cyclic depsipeptides, specifically emodepside, from the open form.
2. **Salt and Crystal Forms of GLP-1R Agonists and Uses Thereof**: This application discloses various salt forms of Compound I and Compound II, characterized by specific properties and physical measurements. It also provides methods for treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.
Conclusion: Xudong Wei's innovative work in pharmaceutical applications highlights his potential impact on health treatments, despite not having any granted patents at this time. His contributions to the synthesis of important compounds may pave the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile